
The episode discusses novel advances and therapeutic expansions in prostate cancer treatment.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QSP865. CME/MOC/AAPA credit will be available until June 29, 2027. Continuing the Innovation Story in Prostate Cancer: Novel Advances and Therapeutic Expansions Across Disease Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Prostate Net. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc., and Johnson & Johnson. Disclosure information is available at the beginning of the video presentation.
Host: PVI, PeerView Institute for Medical Education
Guest: Andrew J. Armstrong, MD, ScM, FACP
Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson
Organizations: The Prostate Net, Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Nurses Credentialing Center (ANCC)
Explore listener stats, chart rankings, contacts and more on the PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast podcast page.